Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine - Related Studies

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine (MERIT)

This study is ongoing, but not recruiting participants.

Study NCT00098293. Last updated on November 10, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV-1

2	Interventions listed in this trial
		Efavirenz + Zidovudine/Lamivudine
		Maraviroc + Zidovudine/Lamivudine

3	Additional drug interventions recognized in this trial
		Efavirenz
		Lamivudine
		Zidovudine

4	More general drug interventions related to this trial
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antimetabolites
		Antiviral Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Reverse Transcriptase Inhibitors
		Therapeutic Uses

5	Sponsors listed in this trial
		Pfizer